Mankind Pharma Limited
Stock Forecast, Prediction & Price Target

Mankind Pharma Limited Financial Estimates

Mankind Pharma Limited Revenue Estimates

Mankind Pharma Limited EBITDA Estimates

Mankind Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹62.14B
 
N/A
₹77.81B
 
25.21%
₹103.34B
 
32.81%
Avg: ₹131.60B
Low: ₹127.76B
High: ₹139.46B
avg. 27.34%
Avg: ₹147.58B
Low: ₹143.87B
High: ₹154.89B
avg. 12.14%
Net Income
 
% change YoY
₹12.65B
 
N/A
₹14.33B
 
13.27%
₹19.12B
 
33.44%
Avg: ₹26.28B
Low: ₹24.36B
High: ₹28.36B
avg. 37.39%
Avg: ₹31.13B
Low: ₹28.52B
High: ₹33.07B
avg. 18.46%
EBITDA
 
% change YoY
₹18.16B
 
N/A
₹20.89B
 
15.04%
₹28.09B
 
34.42%
Avg: ₹34.92B
Low: ₹33.91B
High: ₹37.01B
avg. 24.32%
Avg: ₹39.16B
Low: ₹38.18B
High: ₹41.10B
avg. 12.14%
EPS
 
% change YoY
$31.59
 
N/A
$35.78
 
13.26%
$47.75
 
33.45%
Avg: $65.56
Low: $60.72
High: $70.7
avg. 37.30%
Avg: $77.25
Low: $71.09
High: $82.43
avg. 17.83%
Operating Expenses
 
% change YoY
₹27.82B
 
N/A
₹34.33B
 
23.37%
₹29.27B
 
-14.74%
Avg: ₹16.35B
Low: ₹15.87B
High: ₹17.32B
avg. -44.13%
Avg: ₹18.33B
Low: ₹17.87B
High: ₹19.24B
avg. 12.14%

FAQ

What is Mankind Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 27.92% in 2026-2027.

We have gathered data from 13 analysts. Their low estimate is 24.36B, average is 26.28B and high is 28.36B.

What is Mankind Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 19.74% in 2026-2027.

We have gathered data from 14 analysts. Their low revenue estimate is ₹127.76B, average is ₹131.60B and high is ₹139.46B.

What is Mankind Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 27.56% in 2026-2027.

We have gathered data from 13 analysts. Their low earnings per share estimate is $60.72, average is $65.56 and high is ₹70.7.